 | • レポートコード：MRC2-11QY07428 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はマラリア薬のグローバル市場について調査・分析したレポートです。種類別（アリールアミノアルコール化合物、葉酸拮抗化合物、アルテミシニン化合物）市場規模、用途別（予防、治療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別マラリア薬の競争状況、市場シェア ・世界のマラリア薬市場：種類別市場規模 2015年-2020年（アリールアミノアルコール化合物、葉酸拮抗化合物、アルテミシニン化合物） ・世界のマラリア薬市場：種類別市場規模予測 2021年-2026年（アリールアミノアルコール化合物、葉酸拮抗化合物、アルテミシニン化合物） ・世界のマラリア薬市場：用途別市場規模 2015年-2020年（予防、治療、その他） ・世界のマラリア薬市場：用途別市場規模予測 2021年-2026年（予防、治療、その他） ・北米のマラリア薬市場分析：米国、カナダ ・ヨーロッパのマラリア薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのマラリア薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のマラリア薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのマラリア薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cipla、Guilin Pharmaceutical、IPCA Laboratories、GlaxoSmithKline、Mylan Labs、Roche、Novartis、Sanofi Aventis、Ajanta Pharma、Kunming Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Malaria Drugs Market
The global Malaria Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Malaria Drugs Scope and Market Size
Malaria Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Malaria Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Malaria Drugs market is segmented into
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Segment by Application, the Malaria Drugs market is segmented into
Prevention
Treatment
Other
Regional and Country-level Analysis
The Malaria Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Malaria Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Malaria Drugs Market Share Analysis
Malaria Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Malaria Drugs business, the date to enter into the Malaria Drugs market, Malaria Drugs product introduction, recent developments, etc.
The major vendors covered:
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Kunming Pharmaceutical
1 Study Coverage
1.1 Malaria Drugs Product Introduction
1.2 Market Segments
1.3 Key Malaria Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Malaria Drugs Market Size Growth Rate by Type
1.4.2 Aryl Aminoalcohol Compounds
1.4.3 Antifolate Compounds
1.4.4 Artemisinin Compounds
1.5 Market by Application
1.5.1 Global Malaria Drugs Market Size Growth Rate by Application
1.5.2 Prevention
1.5.3 Treatment
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Malaria Drugs Market Size, Estimates and Forecasts
2.1.1 Global Malaria Drugs Revenue 2015-2026
2.1.2 Global Malaria Drugs Sales 2015-2026
2.2 Global Malaria Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Malaria Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Malaria Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Malaria Drugs Competitor Landscape by Players
3.1 Malaria Drugs Sales by Manufacturers
3.1.1 Malaria Drugs Sales by Manufacturers (2015-2020)
3.1.2 Malaria Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Malaria Drugs Revenue by Manufacturers
3.2.1 Malaria Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Malaria Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Malaria Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Malaria Drugs Revenue in 2019
3.2.5 Global Malaria Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Malaria Drugs Price by Manufacturers
3.4 Malaria Drugs Manufacturing Base Distribution, Product Types
3.4.1 Malaria Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Malaria Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Malaria Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Malaria Drugs Market Size by Type (2015-2020)
4.1.1 Global Malaria Drugs Sales by Type (2015-2020)
4.1.2 Global Malaria Drugs Revenue by Type (2015-2020)
4.1.3 Malaria Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Malaria Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Malaria Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Malaria Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Malaria Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Malaria Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Malaria Drugs Market Size by Application (2015-2020)
5.1.1 Global Malaria Drugs Sales by Application (2015-2020)
5.1.2 Global Malaria Drugs Revenue by Application (2015-2020)
5.1.3 Malaria Drugs Price by Application (2015-2020)
5.2 Malaria Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Malaria Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Malaria Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Malaria Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Malaria Drugs by Country
6.1.1 North America Malaria Drugs Sales by Country
6.1.2 North America Malaria Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Malaria Drugs Market Facts & Figures by Type
6.3 North America Malaria Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Malaria Drugs by Country
7.1.1 Europe Malaria Drugs Sales by Country
7.1.2 Europe Malaria Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Malaria Drugs Market Facts & Figures by Type
7.3 Europe Malaria Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Malaria Drugs by Region
8.1.1 Asia Pacific Malaria Drugs Sales by Region
8.1.2 Asia Pacific Malaria Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Malaria Drugs Market Facts & Figures by Type
8.3 Asia Pacific Malaria Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Malaria Drugs by Country
9.1.1 Latin America Malaria Drugs Sales by Country
9.1.2 Latin America Malaria Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Malaria Drugs Market Facts & Figures by Type
9.3 Central & South America Malaria Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Malaria Drugs by Country
10.1.1 Middle East and Africa Malaria Drugs Sales by Country
10.1.2 Middle East and Africa Malaria Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Malaria Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Malaria Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Description and Business Overview
11.1.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cipla Malaria Drugs Products Offered
11.1.5 Cipla Related Developments
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Corporation Information
11.2.2 Guilin Pharmaceutical Description and Business Overview
11.2.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Guilin Pharmaceutical Malaria Drugs Products Offered
11.2.5 Guilin Pharmaceutical Related Developments
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Corporation Information
11.3.2 IPCA Laboratories Description and Business Overview
11.3.3 IPCA Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.3.4 IPCA Laboratories Malaria Drugs Products Offered
11.3.5 IPCA Laboratories Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Malaria Drugs Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Mylan Labs
11.5.1 Mylan Labs Corporation Information
11.5.2 Mylan Labs Description and Business Overview
11.5.3 Mylan Labs Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Labs Malaria Drugs Products Offered
11.5.5 Mylan Labs Related Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Description and Business Overview
11.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Roche Malaria Drugs Products Offered
11.6.5 Roche Related Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description and Business Overview
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Malaria Drugs Products Offered
11.7.5 Novartis Related Developments
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Description and Business Overview
11.8.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Aventis Malaria Drugs Products Offered
11.8.5 Sanofi Aventis Related Developments
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Corporation Information
11.9.2 Ajanta Pharma Description and Business Overview
11.9.3 Ajanta Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ajanta Pharma Malaria Drugs Products Offered
11.9.5 Ajanta Pharma Related Developments
11.10 Kunming Pharmaceutical
11.10.1 Kunming Pharmaceutical Corporation Information
11.10.2 Kunming Pharmaceutical Description and Business Overview
11.10.3 Kunming Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Kunming Pharmaceutical Malaria Drugs Products Offered
11.10.5 Kunming Pharmaceutical Related Developments
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Description and Business Overview
11.1.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cipla Malaria Drugs Products Offered
11.1.5 Cipla Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Malaria Drugs Market Estimates and Projections by Region
12.1.1 Global Malaria Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Malaria Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Malaria Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Malaria Drugs Sales Forecast (2021-2026)
12.2.2 North America: Malaria Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Malaria Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Malaria Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Malaria Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Malaria Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Malaria Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Malaria Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Malaria Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Malaria Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Malaria Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Malaria Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Malaria Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Malaria Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Malaria Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Malaria Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Malaria Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Malaria Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Malaria Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Malaria Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Malaria Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Malaria Drugs Market Segments
Table 2. Ranking of Global Top Malaria Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Malaria Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Aryl Aminoalcohol Compounds
Table 5. Major Manufacturers of Antifolate Compounds
Table 6. Major Manufacturers of Artemisinin Compounds
Table 7. Global Malaria Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Malaria Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Malaria Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Malaria Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Malaria Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Malaria Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Malaria Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Malaria Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Malaria Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malaria Drugs as of 2019)
Table 16. Malaria Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Malaria Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Malaria Drugs Price (2015-2020) (USD/Unit)
Table 19. Malaria Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Malaria Drugs Product Type
Table 21. Date of International Manufacturers Enter into Malaria Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Malaria Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Malaria Drugs Sales Share by Type (2015-2020)
Table 25. Global Malaria Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Malaria Drugs Revenue Share by Type (2015-2020)
Table 27. Malaria Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Malaria Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Malaria Drugs Sales Share by Application (2015-2020)
Table 30. North America Malaria Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Malaria Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Malaria Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Malaria Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Malaria Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Malaria Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Malaria Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Malaria Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Malaria Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Malaria Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Malaria Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Malaria Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Malaria Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Malaria Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Malaria Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Malaria Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Malaria Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Malaria Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Malaria Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Malaria Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Malaria Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Malaria Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Malaria Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Malaria Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Malaria Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Malaria Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Malaria Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Malaria Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Malaria Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Malaria Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Malaria Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Malaria Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Malaria Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Malaria Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Malaria Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Malaria Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Malaria Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Malaria Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Malaria Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Malaria Drugs Sales Market Share by Application (2015-2020)
Table 70. Cipla Corporation Information
Table 71. Cipla Description and Major Businesses
Table 72. Cipla Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Cipla Product
Table 74. Cipla Recent Development
Table 75. Guilin Pharmaceutical Corporation Information
Table 76. Guilin Pharmaceutical Description and Major Businesses
Table 77. Guilin Pharmaceutical Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Guilin Pharmaceutical Product
Table 79. Guilin Pharmaceutical Recent Development
Table 80. IPCA Laboratories Corporation Information
Table 81. IPCA Laboratories Description and Major Businesses
Table 82. IPCA Laboratories Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. IPCA Laboratories Product
Table 84. IPCA Laboratories Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Major Businesses
Table 87. GlaxoSmithKline Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Mylan Labs Corporation Information
Table 91. Mylan Labs Description and Major Businesses
Table 92. Mylan Labs Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Mylan Labs Product
Table 94. Mylan Labs Recent Development
Table 95. Roche Corporation Information
Table 96. Roche Description and Major Businesses
Table 97. Roche Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Roche Product
Table 99. Roche Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Major Businesses
Table 102. Novartis Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Novartis Product
Table 104. Novartis Recent Development
Table 105. Sanofi Aventis Corporation Information
Table 106. Sanofi Aventis Description and Major Businesses
Table 107. Sanofi Aventis Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Aventis Product
Table 109. Sanofi Aventis Recent Development
Table 110. Ajanta Pharma Corporation Information
Table 111. Ajanta Pharma Description and Major Businesses
Table 112. Ajanta Pharma Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Ajanta Pharma Product
Table 114. Ajanta Pharma Recent Development
Table 115. Kunming Pharmaceutical Corporation Information
Table 116. Kunming Pharmaceutical Description and Major Businesses
Table 117. Kunming Pharmaceutical Malaria Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Kunming Pharmaceutical Product
Table 119. Kunming Pharmaceutical Recent Development
Table 120. Global Malaria Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Malaria Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Malaria Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Malaria Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Malaria Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Malaria Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Malaria Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Malaria Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Malaria Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Malaria Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Malaria Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Malaria Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Malaria Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Malaria Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Malaria Drugs Players
Table 138. Malaria Drugs Customers List
Table 139. Malaria Drugs Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Malaria Drugs Product Picture
Figure 2. Global Malaria Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Aryl Aminoalcohol Compounds Product Picture
Figure 4. Antifolate Compounds Product Picture
Figure 5. Artemisinin Compounds Product Picture
Figure 6. Global Malaria Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Other
Figure 10. Malaria Drugs Report Years Considered
Figure 11. Global Malaria Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Malaria Drugs Sales 2015-2026 (K Units)
Figure 13. Global Malaria Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Malaria Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Malaria Drugs Sales Market Share by Region in 2019
Figure 16. Global Malaria Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Malaria Drugs Revenue Market Share by Region in 2019
Figure 18. Global Malaria Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Malaria Drugs Revenue in 2019
Figure 20. Malaria Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Malaria Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Malaria Drugs Sales Market Share by Type in 2019
Figure 23. Global Malaria Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Malaria Drugs Revenue Market Share by Type in 2019
Figure 25. Global Malaria Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Malaria Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Malaria Drugs Sales Market Share by Application in 2019
Figure 28. Global Malaria Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Malaria Drugs Revenue Market Share by Application in 2019
Figure 30. North America Malaria Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Malaria Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Malaria Drugs Sales Market Share by Country in 2019
Figure 33. North America Malaria Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Malaria Drugs Market Share by Type in 2019
Figure 39. North America Malaria Drugs Market Share by Application in 2019
Figure 40. Europe Malaria Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Malaria Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Malaria Drugs Sales Market Share by Country in 2019
Figure 43. Europe Malaria Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Malaria Drugs Market Share by Type in 2019
Figure 55. Europe Malaria Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Malaria Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Malaria Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Malaria Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Malaria Drugs Revenue Market Share by Region in 2019
Figure 60. China Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Malaria Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Malaria Drugs Market Share by Application in 2019
Figure 84. Latin America Malaria Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Malaria Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Malaria Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Malaria Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Malaria Drugs Market Share by Type in 2019
Figure 95. Latin America Malaria Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Malaria Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Malaria Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Malaria Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Malaria Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Malaria Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Malaria Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Malaria Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Malaria Drugs Market Share by Application in 2019
Figure 108. North America Malaria Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Malaria Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Malaria Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Malaria Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Malaria Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Malaria Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Malaria Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Malaria Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Malaria Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Malaria Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
脳マラリア治療薬の世界市場（～2026年） During cerebral malaria there is a state of unarousable coma with malaria infected blood in the peripheral circulation. The condition of coma is due to some other type of infections or hypoglycemia. The presence of retinopathy has been an addition in the clinical diagnosis of both adult and children…- 白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 喘息治療薬の世界市場（～2026年） Market Analysis and Insights: Global Asthma Treatment Drugs Market The global Asthma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Asthma Treatment Drugs Scope and Market Size Asthma Treatment Drugs m…